Gene-guided healthcare has taken U.S. medicine by storm, promising precision, targeted treatments to myriad illnesses. It has also proved very profitable. James Tabery traces how genetic medicine vied within the federal government with another approach to healthcare — one emphasizing the social and environmental determinants of health, such as whether you live in a polluted neighborhood — and triumphed over it. He argues that private industry has benefited, while public health has suffered. (Encore presentation.)
Resources:
James Tabery, Tyranny of the Gene: Personalized Medicine and Its Threat to Public Health Knopf, 2023
Photo credit: Dave Titensor
The post The Price of Gene-Based Medicine appeared first on KPFA.
Ukrainian Anarchist
The Unfair Benefits of Marriage
Extraction’s Heavy Toll
The Plastics Recycling Deception
Food & Freedom
The Politics of Camping
Fund Drive Special: Mastering Time?
Fund Drive Special: Allen Ginsberg
Fund Drive Special: Where We Came From, Where We’re Going
Fund Drive Special: Forceful Females
Fund Drive Special: Rebuilding Habitats in Our Yard
Fund Drive Special: Paul Stamets on Mushrooms
Fund Drive Special: Israeli Universities and the State
Fund Drive Special: A New “Lies My Teacher Told Me”
The Fall and Rise of U.S. Finance
May Day Meanings
Socialism to Capitalism
Commodifying Water
Edward Said’s Vision
Exploiting Refugees
Create your
podcast in
minutes
It is Free
KPFA - The Pacifica Evening News, Weekdays
KPFA - Over the Edge
KPFA - Exploration
KPFA - Full Circle
KPFA - Cover to Cover with Jennifer Stone